Using IVS3 device for upper limb recovery in stroke patients
A Pilot Study on Tolerance and Ease of Implementation of Intensive Visual Stimulation (IVS3) in Daily Practice for Upper Limb Motor Recovery in Outpatient Rehab Center
This study is testing if using a special device called IVS3 can help stroke patients recover their arm function better when combined with regular therapy.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 25 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Weill Medical College of Cornell University Academic / other |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT06483230 on ClinicalTrials.gov |
What this trial studies
This study investigates the use of the Intensive Visual Stimulation three (IVS3) device in outpatient rehabilitation for individuals with chronic stroke. Participants will engage with the IVS3 device for 30 minutes alongside conventional treatment for 15 minutes over 12 sessions within a 4-6 week period. The study aims to assess both participant satisfaction and improvements in upper extremity function, particularly focusing on those with and without hemispatial neglect. It is an open-label phase I/II study conducted at Weill Cornell Medicine.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who have experienced a stroke at least 6 months prior and have moderate upper extremity impairments.
Not a fit: Patients with significant spasticity, severe visual impairments, or those currently receiving concurrent occupational therapy may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance upper limb recovery and improve quality of life for stroke patients.
How similar studies have performed: While this approach is innovative, similar studies exploring visual stimulation for motor recovery have shown promising results.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥ 18 years old 2. English speaking 3. History of ischemic or hemorrhagic stroke ≥ 6 months prior to study enrolment 4. FMA-UE: 20 \< x \< 50 (moderate impairments) 5. With or without hemi spatial neglect Exclusion Criteria: 1. Spasticity or increased tone with MAS ≥3 in the upper extremity 2. Unable to communicate effectively or provide informed consent 3. Significant visual impairments 4. Concurrent occupational therapy being received outside of the study 5. Pregnant or incarcerated individuals
Where this trial is running
New York, New York
- Weill Cornell Medicine, 525 E. 68th St, Baker Pavilion, F-2106 — New York, New York, United States (Recruiting)
Study contacts
- Principal investigator: Joan Stilling, MD,MS — Weill Medical College of Cornell University
- Study coordinator: Zhiyan Yang, MS
- Email: zhy7009@med.cornell.edu
- Phone: (212) 746-1509
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.